It is the cache of http://www.opticon1826.com/article/view/70. It is a snapshot of the page. The current page could have changed in the meantime.
Tip: To quickly find your search term on this page, press Ctrl+F or ⌘-F (Mac) and use the find bar.

Translational Research | Fleming | Opticon1826

Translational Research

Stephen M. Fleming

Abstract

A cursory glance through recent issues of the leading science journals that are found lying on your average university coffee table ( Nature, Science, PNAS) will be enough to convince you that UCL Life Sciences are thriving. With alumni as illustrious as the molecular biologist Francis Crick and evolutionary theorist John Maynard Smith, this shouldn’t come as too much of a surprise. But now UCL is also leading the way with so-called ‘translational’ research – medical science that seamlessly strides into the public domain, with the potential to directly impact on people’s lives. Think penicillin, anti-depressants and polio vaccinations, and you’re on the right lines.

View the full article: PDF

How to cite: Fleming, S.M. 2009. Translational Research. Opticon1826 (6), DOI: http://dx.doi.org/10.5334/opt.060910

This is an Open Access article distributed under the terms of the Creative Commons Attribution License
(http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Copyright is retained by the author(s).

Published on 1 April 2009.

ISSN: 2049-8128 | Published by Ubiquity Press | Creative Commons License This work is licensed under a Creative Commons License.